The increase in IFN-γ producing cells in the gut suggests a protective activity of the VRC01-Rh-α4β7 combination on the gut immune system and helps explain the long-term survival of SIV infected animals treated with Rh-α4β7 during acute infection (reported at CROI 2018 by J. Arthos [56]). Here, IFNG is linked to infection.